Report banner
Home
Industries
Healthcare
Pharmaceutical
report thumbnailOphthalmic Disease Therapeutics Market

Ophthalmic Disease Therapeutics Market 2024-2032 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Ophthalmic Disease Therapeutics Market by Drug Class (Anti-inflammatory, Anti-infectives, Anti-VEGF, Anti-glaucoma {Beta Blockers, Prostaglandins Analogs, Alpha Adrenergic Agonists}), by Dosage Form (Solid, Liquid, & Semisolid), by Disease Indication (Glaucoma {Open Angle Glaucoma, Angle Closure Glaucoma}, Dry Eye Disease, Retinal Diseases {Diabetic Macular Edema, Macular Degeneration}, Allergy & Infections), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies), by North America (U.S., Canada) Forecast 2024-2032

Nov 16 2024
Base Year: 2023
150 Pages
Market Research Future Logo

Ophthalmic Disease Therapeutics Market 2024-2032 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Key Insights

The Ophthalmic Disease Therapeutics Marketsize was valued at USD 33.56 USD billion in 2023 and is projected to reach USD 51.81 USD billion by 2032, exhibiting a CAGR of 6.4 % during the forecast period. Ophthalmic Disease Therapeutics describes drugs, surgical procedures, and gene therapy strategies to cure or mitigate diseases of the eye such as glaucoma, macular degeneration, and diabetic retinopathy. Some of the important categories are anti-inflammatory drugs, anti-VEGF agents, and intraocular pressure-lowering medications. The characteristic of these therapeutics is that they have a carrier to the target site usually in the form of eye drops, injections, or implants to boost its effectiveness while reducing side effects. Examples span from maintaining vision to averting blindness and enhancing the standard of living of the afflicted patients with assorted ailments affecting the eyes, making progress within this area vital because of the increasing rate of ocular complications.

Ophthalmic Disease Therapeutics Market Research Report - Market Size, Growth & Forecast

Ophthalmic Disease Therapeutics Trends

  • Increasing prevalence of chronic ophthalmic diseases
  • Rising adoption of biologics and intraocular devices
  • Focus on personalized and targeted therapies

Driving Forces: What's Propelling the Ophthalmic Disease Therapeutics Market

  • Growing senior population: The aging population's increasing susceptibility to eye diseases such as glaucoma and macular degeneration fuels the demand for ophthalmic therapies.
  • Technological advancements: Breakthroughs in imaging modalities like optical coherence tomography (OCT) and improvements in drug delivery systems like intravitreal injections have paved the way for precise and less invasive treatments.
  • Increased disposable income: Rising disposable income in emerging markets like China and India expands access to ophthalmic care and therapies, driving market growth.
  • Prevalence of chronic eye diseases: The rise in chronic eye diseases such as diabetic retinopathy and uveitis further underscores the need for effective treatments.
  • Government initiatives and awareness campaigns: Governmental support and initiatives to promote eye health awareness and access to treatment contribute to market growth.

Challenges and Restraints in Ophthalmic Disease Therapeutics Market

  • High costs of treatments: The high cost of biologics and other specialized therapies can limit accessibility for some patients.
  • Lack of skilled ophthalmologists: Shortages of trained ophthalmologists in underserved areas can delay diagnosis and treatment.
  • Side effects of therapies: Some ophthalmic treatments can cause side effects, which can discourage patients from adhering to therapy.

Emerging Trends in Ophthalmic Disease Therapeutics

  • Gene therapy: Gene therapy holds the potential for treating inherited eye diseases like retinitis pigmentosa.
  • Artificial intelligence (AI) in diagnosis: AI-powered algorithms assist in early detection and personalized treatment planning.
  • Telemedicine for ophthalmology: Telemedicine platforms provide remote access to ophthalmic care, improving accessibility in remote areas.

Growth Catalysts in the Ophthalmic Disease Therapeutics Industry

Ophthalmic Disease Therapeutics Market Growth
  • Strategic collaborations: Partnerships between pharmaceutical companies and academic institutions accelerate research and development.
  • Government initiatives: Governments are investing in research and accessibility programs to address ophthalmic diseases.
  • Emerging markets: Untapped potential in developing countries offers a significant growth opportunity for ophthalmic disease therapeutics.

Market Segmentation: Ophthalmic Disease Therapeutics Analysis

Drug Class:

  • Anti-inflammatory
  • Anti-infectives
  • Anti-VEGF
  • Anti-glaucoma

Dosage Form:

  • Solid
  • Liquid
  • Semisolid

Disease Indication:

  • Glaucoma
  • Dry Eye Disease
  • Retinal Diseases
  • Allergy & Infections

Distribution Channel:

  • Hospital Pharmacies
  • Retail & Online Pharmacies

Leading Players in the Ophthalmic Disease Therapeutics Market

  • Regeneron Pharmaceuticals Inc. (U.S.)
  • AbbVie Inc. (U.S.)
  • Santen Pharmaceutical Co. Ltd. (Japan)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Viatris Inc. (U.S.)
  • Allergan (U.S.)
  • Alcon (Switzerland)
  • Bausch + Lomb (Canada)

Significant Developments in the Ophthalmic Disease Therapeutics Sector

  • 2022: Novartis receives FDA approval for Beovu, a novel treatment for wet age-related macular degeneration.
  • 2021: Roche and Genentech launch Vabysmo, a long-acting injection for wet age-related macular degeneration.
  • 2020: Allergan (now AbbVie) acquires Akarna Therapeutics for its gene therapy platform targeting rare inherited retinal diseases.

Comprehensive Coverage Ophthalmic Disease Therapeutics Market Report

This comprehensive report provides an in-depth examination of the ophthalmic disease therapeutics market. It encompasses market size projections, growth drivers, key challenges, market segmentation, a review of the competitive landscape, and insights into current industry trends. With its detailed analysis, this report empowers stakeholders to make informed decisions and capitalize on market opportunities.

Regional Insight

Ophthalmic Disease Therapeutics Market Regional Share

The market report provides insights into the regional dynamics of the ophthalmic disease therapeutics market, including regional market size, growth rates, and key market trends in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Pricing Analysis

The report provides a detailed analysis of pricing trends and factors influencing pricing in the ophthalmic disease therapeutics market.

Ophthalmic Disease Therapeutics Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 6.4% from 2018-2032
Segmentation
    • By Drug Class
      • Anti-inflammatory
      • Anti-infectives
      • Anti-VEGF
      • Anti-glaucoma {Beta Blockers
      • Prostaglandins Analogs
      • Alpha Adrenergic Agonists}
    • By Dosage Form
      • Solid
      • Liquid
      • & Semisolid
    • By Disease Indication
      • Glaucoma {Open Angle Glaucoma
      • Angle Closure Glaucoma}
      • Dry Eye Disease
      • Retinal Diseases {Diabetic Macular Edema
      • Macular Degeneration}
      • Allergy & Infections
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail & Online Pharmacies
  • By Geography
    • North America
      • U.S.
      • Canada

Frequently Asked Questions

Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Rising Prevalence of Ophthalmic Conditions to Surge the Demand for Innovative Drugs
      • 3.3. Market Restrains
        • 3.3.1. High Cost of Biologics and Overall Treatment Cost is Limiting the Adoption of the Product
      • 3.4. Market Trends
        • 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2030
    • 5.1. Market Analysis, Insights and Forecast - by Drug Class
      • 5.1.1. Anti-inflammatory
      • 5.1.2. Anti-infectives
      • 5.1.3. Anti-VEGF
      • 5.1.4. Anti-glaucoma {Beta Blockers
      • 5.1.5. Prostaglandins Analogs
      • 5.1.6. Alpha Adrenergic Agonists}
    • 5.2. Market Analysis, Insights and Forecast - by Dosage Form
      • 5.2.1. Solid
      • 5.2.2. Liquid
      • 5.2.3. & Semisolid
    • 5.3. Market Analysis, Insights and Forecast - by Disease Indication
      • 5.3.1. Glaucoma {Open Angle Glaucoma
      • 5.3.2. Angle Closure Glaucoma}
      • 5.3.3. Dry Eye Disease
      • 5.3.4. Retinal Diseases {Diabetic Macular Edema
      • 5.3.5. Macular Degeneration}
      • 5.3.6. Allergy & Infections
    • 5.4. Market Analysis, Insights and Forecast - by Distribution Channel
      • 5.4.1. Hospital Pharmacies
      • 5.4.2. Retail & Online Pharmacies
    • 5.5. Market Analysis, Insights and Forecast - by Region
      • 5.5.1. North America
  6. 6. North America Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 6.1. Market Analysis, Insights and Forecast - By Drug Class
        • 6.1.1 Anti-inflammatory
        • 6.1.2 Anti-infectives
        • 6.1.3 Anti-VEGF
        • 6.1.4 and Anti-glaucoma
      • 6.2. Market Analysis, Insights and Forecast - By Dosage Form
        • 6.2.1 Solid
        • 6.2.2 Liquid
        • 6.2.3 and Semisolid
      • 6.3. Market Analysis, Insights and Forecast - By Disease Indication
        • 6.3.1 Glaucoma
        • 6.3.2 Dry Eye Disease
        • 6.3.3 Retinal Diseases
        • 6.3.4 and Allergy & Infections
      • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
        • 6.4.1. Hospital Pharmacies and Retail & Online Pharmacies
      • 6.5. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 6.5.1 United States
        • 6.5.2 Canada
        • 6.5.3 Mexico
        • 6.5.4 Rest of North America
  7. 7. Middle East & Africa Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 7.1. Market Analysis, Insights and Forecast - By Drug Class
        • 7.1.1 Anti-inflammatory
        • 7.1.2 Anti-infectives
        • 7.1.3 Anti-VEGF
        • 7.1.4 and Anti-glaucoma
      • 7.2. Market Analysis, Insights and Forecast - By Dosage Form
        • 7.2.1 Solid
        • 7.2.2 Liquid
        • 7.2.3 and Semisolid
      • 7.3. Market Analysis, Insights and Forecast - By Disease Indication
        • 7.3.1 Glaucoma
        • 7.3.2 Dry Eye Disease
        • 7.3.3 Retinal Diseases
        • 7.3.4 and Allergy & Infections
      • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
        • 7.4.1. Hospital Pharmacies and Retail & Online Pharmacies
      • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 7.5.1 UAE
        • 7.5.2 South Africa
        • 7.5.3 Saudi Arabia
        • 7.5.4 Rest of MEA
  8. 8. Asia Pacific Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 8.1. Market Analysis, Insights and Forecast - By Drug Class
        • 8.1.1 Anti-inflammatory
        • 8.1.2 Anti-infectives
        • 8.1.3 Anti-VEGF
        • 8.1.4 and Anti-glaucoma
      • 8.2. Market Analysis, Insights and Forecast - By Dosage Form
        • 8.2.1 Solid
        • 8.2.2 Liquid
        • 8.2.3 and Semisolid
      • 8.3. Market Analysis, Insights and Forecast - By Disease Indication
        • 8.3.1 Glaucoma
        • 8.3.2 Dry Eye Disease
        • 8.3.3 Retinal Diseases
        • 8.3.4 and Allergy & Infections
      • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
        • 8.4.1. Hospital Pharmacies and Retail & Online Pharmacies
      • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 8.5.1 China
        • 8.5.2 Japan
        • 8.5.3 India
        • 8.5.4 South Korea
        • 8.5.5 Taiwan
        • 8.5.6 Australia
        • 8.5.7 Rest of Asia-Pacific
  9. 9. Europe Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 9.1. Market Analysis, Insights and Forecast - By Drug Class
        • 9.1.1 Anti-inflammatory
        • 9.1.2 Anti-infectives
        • 9.1.3 Anti-VEGF
        • 9.1.4 and Anti-glaucoma
      • 9.2. Market Analysis, Insights and Forecast - By Dosage Form
        • 9.2.1 Solid
        • 9.2.2 Liquid
        • 9.2.3 and Semisolid
      • 9.3. Market Analysis, Insights and Forecast - By Disease Indication
        • 9.3.1 Glaucoma
        • 9.3.2 Dry Eye Disease
        • 9.3.3 Retinal Diseases
        • 9.3.4 and Allergy & Infections
      • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
        • 9.4.1. Hospital Pharmacies and Retail & Online Pharmacies
      • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 9.5.1 Germany
        • 9.5.2 France
        • 9.5.3 Italy
        • 9.5.4 United Kingdom
        • 9.5.5 Netherlands
        • 9.5.6 Rest of Europe
  10. 10. South America Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2030
      • 10.1. Market Analysis, Insights and Forecast - By Drug Class
        • 10.1.1 Anti-inflammatory
        • 10.1.2 Anti-infectives
        • 10.1.3 Anti-VEGF
        • 10.1.4 and Anti-glaucoma
      • 10.2. Market Analysis, Insights and Forecast - By Dosage Form
        • 10.2.1 Solid
        • 10.2.2 Liquid
        • 10.2.3 and Semisolid
      • 10.3. Market Analysis, Insights and Forecast - By Disease Indication
        • 10.3.1 Glaucoma
        • 10.3.2 Dry Eye Disease
        • 10.3.3 Retinal Diseases
        • 10.3.4 and Allergy & Infections
      • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
        • 10.4.1. Hospital Pharmacies and Retail & Online Pharmacies
      • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 10.5.1 Brazil
        • 10.5.2 Argentina
        • 10.5.3 Rest of South America
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2023
      • 11.2. Company Profiles
        • 11.2.1 Regeneron Pharmaceuticals Inc. (U.S)
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 AbbVie Inc. (U.S.)
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 Santen Pharmaceutical Co. Ltd. (Japan)
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Novartis AG (Switzerland)
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Bayer AG (Germany)
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 F. Hoffmann-La Roche Ltd. (Switzerland)
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Viatris Inc. (U.S.)
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Allergan (U.S.)
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Alcon (Switzerland)
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 Bausch + Lomb (Canada)
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Ophthalmic Disease Therapeutics Market Revenue Breakdown (USD billion, %) by Region 2023 & 2031
  2. Figure 2: Global Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Drug Class 2023 & 2031
  3. Figure 3: Global Ophthalmic Disease Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  4. Figure 4: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Anti-inflammatory 2020 & 2031
  5. Figure 5: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Anti-infectives 2020 & 2031
  6. Figure 6: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Anti-VEGF 2020 & 2031
  7. Figure 7: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Anti-glaucoma {Beta Blockers 2020 & 2031
  8. Figure 8: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Prostaglandins Analogs 2020 & 2031
  9. Figure 9: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Alpha Adrenergic Agonists} 2020 & 2031
  10. Figure 10: Global Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Dosage Form 2023 & 2031
  11. Figure 11: Global Ophthalmic Disease Therapeutics Market Revenue Share (%), by Dosage Form 2023 & 2031
  12. Figure 12: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Solid 2020 & 2031
  13. Figure 13: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Liquid 2020 & 2031
  14. Figure 14: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by & Semisolid 2020 & 2031
  15. Figure 15: Global Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Disease Indication 2023 & 2031
  16. Figure 16: Global Ophthalmic Disease Therapeutics Market Revenue Share (%), by Disease Indication 2023 & 2031
  17. Figure 17: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Glaucoma {Open Angle Glaucoma 2020 & 2031
  18. Figure 18: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Angle Closure Glaucoma} 2020 & 2031
  19. Figure 19: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Dry Eye Disease 2020 & 2031
  20. Figure 20: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Retinal Diseases {Diabetic Macular Edema 2020 & 2031
  21. Figure 21: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Macular Degeneration} 2020 & 2031
  22. Figure 22: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Allergy & Infections 2020 & 2031
  23. Figure 23: Global Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Distribution Channel 2023 & 2031
  24. Figure 24: Global Ophthalmic Disease Therapeutics Market Revenue Share (%), by Distribution Channel 2023 & 2031
  25. Figure 25: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Hospital Pharmacies 2020 & 2031
  26. Figure 26: Global Ophthalmic Disease Therapeutics Market Forecast (USD billion), by Retail & Online Pharmacies 2020 & 2031
  27. Figure 27: Global Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Region 2023 & 2031
  28. Figure 28: Global Ophthalmic Disease Therapeutics Market Revenue Share (%), by Region 2023 & 2031
  29. Figure 29: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Drug Class 2023 & 2031
  30. Figure 30: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  31. Figure 31: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Dosage Form 2023 & 2031
  32. Figure 32: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Dosage Form 2023 & 2031
  33. Figure 33: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Disease Indication 2023 & 2031
  34. Figure 34: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Disease Indication 2023 & 2031
  35. Figure 35: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Distribution Channel 2023 & 2031
  36. Figure 36: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Distribution Channel 2023 & 2031
  37. Figure 37: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Country 2023 & 2031
  38. Figure 38: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  39. Figure 39: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Drug Class 2023 & 2031
  40. Figure 40: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  41. Figure 41: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Dosage Form 2023 & 2031
  42. Figure 42: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue Share (%), by Dosage Form 2023 & 2031
  43. Figure 43: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Disease Indication 2023 & 2031
  44. Figure 44: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue Share (%), by Disease Indication 2023 & 2031
  45. Figure 45: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Distribution Channel 2023 & 2031
  46. Figure 46: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue Share (%), by Distribution Channel 2023 & 2031
  47. Figure 47: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Country 2023 & 2031
  48. Figure 48: Middle East & Africa Ophthalmic Disease Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  49. Figure 49: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Drug Class 2023 & 2031
  50. Figure 50: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  51. Figure 51: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Dosage Form 2023 & 2031
  52. Figure 52: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue Share (%), by Dosage Form 2023 & 2031
  53. Figure 53: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Disease Indication 2023 & 2031
  54. Figure 54: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue Share (%), by Disease Indication 2023 & 2031
  55. Figure 55: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Distribution Channel 2023 & 2031
  56. Figure 56: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue Share (%), by Distribution Channel 2023 & 2031
  57. Figure 57: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Country 2023 & 2031
  58. Figure 58: Asia Pacific Ophthalmic Disease Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  59. Figure 59: Europe Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Drug Class 2023 & 2031
  60. Figure 60: Europe Ophthalmic Disease Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  61. Figure 61: Europe Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Dosage Form 2023 & 2031
  62. Figure 62: Europe Ophthalmic Disease Therapeutics Market Revenue Share (%), by Dosage Form 2023 & 2031
  63. Figure 63: Europe Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Disease Indication 2023 & 2031
  64. Figure 64: Europe Ophthalmic Disease Therapeutics Market Revenue Share (%), by Disease Indication 2023 & 2031
  65. Figure 65: Europe Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Distribution Channel 2023 & 2031
  66. Figure 66: Europe Ophthalmic Disease Therapeutics Market Revenue Share (%), by Distribution Channel 2023 & 2031
  67. Figure 67: Europe Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Country 2023 & 2031
  68. Figure 68: Europe Ophthalmic Disease Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  69. Figure 69: South America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Drug Class 2023 & 2031
  70. Figure 70: South America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  71. Figure 71: South America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Dosage Form 2023 & 2031
  72. Figure 72: South America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Dosage Form 2023 & 2031
  73. Figure 73: South America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Disease Indication 2023 & 2031
  74. Figure 74: South America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Disease Indication 2023 & 2031
  75. Figure 75: South America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Distribution Channel 2023 & 2031
  76. Figure 76: South America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Distribution Channel 2023 & 2031
  77. Figure 77: South America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Country 2023 & 2031
  78. Figure 78: South America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Country 2023 & 2031
  79. Figure 79: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Drug Class 2023 & 2031
  80. Figure 80: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Drug Class 2023 & 2031
  81. Figure 81: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Dosage Form 2023 & 2031
  82. Figure 82: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Dosage Form 2023 & 2031
  83. Figure 83: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Disease Indication 2023 & 2031
  84. Figure 84: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Disease Indication 2023 & 2031
  85. Figure 85: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Distribution Channel 2023 & 2031
  86. Figure 86: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Distribution Channel 2023 & 2031
  87. Figure 87: North America Ophthalmic Disease Therapeutics Market Revenue (USD billion), by Country 2023 & 2031
  88. Figure 88: North America Ophthalmic Disease Therapeutics Market Revenue Share (%), by Country 2023 & 2031
List of Tables
  1. Table 1: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  2. Table 2: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  3. Table 3: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  4. Table 4: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  5. Table 5: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Region 2018 & 2031
  6. Table 6: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  7. Table 7: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  8. Table 8: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  9. Table 9: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  10. Table 10: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Region 2018 & 2031
  11. Table 11: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  12. Table 12: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  13. Table 13: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  14. Table 14: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  15. Table 15: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
  16. Table 16: United States Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  17. Table 17: Canada Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  18. Table 18: Mexico Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  19. Table 19: Rest of North America Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  20. Table 20: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  21. Table 21: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  22. Table 22: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  23. Table 23: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  24. Table 24: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
  25. Table 25: UAE Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  26. Table 26: South Africa Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  27. Table 27: Saudi Arabia Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  28. Table 28: Rest of MEA Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  29. Table 29: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  30. Table 30: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  31. Table 31: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  32. Table 32: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  33. Table 33: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
  34. Table 34: China Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  35. Table 35: Japan Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  36. Table 36: India Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  37. Table 37: South Korea Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  38. Table 38: Taiwan Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  39. Table 39: Australia Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  40. Table 40: Rest of Asia-Pacific Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  41. Table 41: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  42. Table 42: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  43. Table 43: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  44. Table 44: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  45. Table 45: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
  46. Table 46: Germany Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  47. Table 47: France Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  48. Table 48: Italy Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  49. Table 49: United Kingdom Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  50. Table 50: Netherlands Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  51. Table 51: Rest of Europe Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  52. Table 52: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  53. Table 53: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  54. Table 54: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  55. Table 55: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  56. Table 56: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
  57. Table 57: Brazil Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  58. Table 58: Argentina Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  59. Table 59: Rest of South America Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  60. Table 60: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Drug Class 2018 & 2031
  61. Table 61: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Dosage Form 2018 & 2031
  62. Table 62: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Disease Indication 2018 & 2031
  63. Table 63: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Distribution Channel 2018 & 2031
  64. Table 64: Global Ophthalmic Disease Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
  65. Table 65: U.S. Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  66. Table 66: Canada Ophthalmic Disease Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 6.4% from 2018-2032
Segmentation
    • By Drug Class
      • Anti-inflammatory
      • Anti-infectives
      • Anti-VEGF
      • Anti-glaucoma {Beta Blockers
      • Prostaglandins Analogs
      • Alpha Adrenergic Agonists}
    • By Dosage Form
      • Solid
      • Liquid
      • & Semisolid
    • By Disease Indication
      • Glaucoma {Open Angle Glaucoma
      • Angle Closure Glaucoma}
      • Dry Eye Disease
      • Retinal Diseases {Diabetic Macular Edema
      • Macular Degeneration}
      • Allergy & Infections
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail & Online Pharmacies
  • By Geography
    • North America
      • U.S.
      • Canada

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Get Free Sample
Hover animation image
 Pre Order Enquiry Request discount

Pricing

$4850
Single User License:
  • Only one user can access this report at time
  • users are not allowed to take a print out of the report PDF
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • This is a multi-user license, allowing 1-10 employees within your organisation to access the report.
$6850
Corporate User License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
BUY NOW
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

+1 2017933837

+44 20 7097 9277

sales@marketresearchforecast.com

  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
MRF logo
  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
sales@marketresearchforecast.com

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 940 441 3937

sales@marketresearchforecast.com

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2024 AMA Research. All rights reserved

Privacy Policy
Terms and Conditions
FAQ

Related Reports

report thumbnailFemale Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market 2024 to Grow at 1...

report thumbnailUrinary Drainage Bags Market

Urinary Drainage Bags Market Analysis Report 2024: Market to...

report thumbnailGuidewires Market

Guidewires Market 2024 to Grow at 21.2 CAGR with XX USD mill...

report thumbnailAsia Pacific In-vitro Diagnostics Market

Asia Pacific In-vitro Diagnostics Market Analysis 2024 and F...

report thumbnailBrain Implants Market

Brain Implants Market Charting Growth Trajectories: Analysis...

report thumbnailContinuous Renal Replacement Therapy (CRRT) Market

Continuous Renal Replacement Therapy (CRRT) Market Future-pr...

report thumbnailFoot Prosthetics Market

Foot Prosthetics Market 2024 to Grow at 6.6 CAGR with 588.1 ...

report thumbnailImmunoglobulins Market

Immunoglobulins Market Decade Long Trends, Analysis and Fore...

report thumbnailNegative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy (NPWT) Market Is Set To Reac...

report thumbnailViral Vaccines Market

Viral Vaccines Market Unlocking Growth Opportunities: Analys...

report thumbnailNeurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market 2024 t...

report thumbnailU.S. Normal Saline for Parenteral Use Market

U.S. Normal Saline for Parenteral Use Market  Analysis Repor...

report thumbnailHealthcare Predictive Analytics Market

Healthcare Predictive Analytics Market Decade Long Trends, A...

report thumbnailStomach-Gastric- Cancer- Treatment Market

Stomach-Gastric- Cancer- Treatment Market Decade Long Trends...

report thumbnailBiomarkers Market

Biomarkers Market Report Probes the 38.41 USD billion Size, ...

report thumbnailAntiepileptic Drug Market

Antiepileptic Drug Market 2024-2032 Analysis: Trends, Compet...

report thumbnailSurgical Stapling Devices Market

Surgical Stapling Devices Market Insightful Analysis: Trends...

report thumbnailUrinary Catheter Market

Urinary Catheter Market Report Probes the 2.56 USD Billion S...

report thumbnailAdult Diapers Market

Adult Diapers Market Is Set To Reach 11.55 USD Billion By 20...

report thumbnailSpectacles Market

Spectacles Market 2024 to Grow at 5.7 CAGR with 91.56 USD bi...